FIELD: printing equipment.
SUBSTANCE: marking for the substrate is proposed. Marking comprises at least one luminescent substance (a) and at least one material (b) based on a chiral liquid crystal polymer (CLCP). Wavelength range of the reflection waves overlaps at least part of the luminescence wavelength range (a). At least a portion of the luminescent substance (a) is disposed under the chiral fatty crystal polymer material (b).
EFFECT: marking containing the chiral liquid crystal polymer and the luminescent substance has been proposed.
19 cl, 7 dwg
Title | Year | Author | Number |
---|---|---|---|
CHIRAL LIQUID CRYSTAL POLYMER LAYER OR PATTERN COMPRISING RANDOMLY DISTRIBUTED CRATERS THEREIN | 2013 |
|
RU2670673C9 |
METHODS OF ROTOGRAVURE PRINTING FOR OBTAINING OPTICALLY CHANGING SIGNS OF PROTECTION | 2014 |
|
RU2640269C2 |
4,6,7,13-SUBSTITUTED DERIVATIVES OF 1-BENZYLISOQUINOLINE AND PHARMACEUTICAL COMPOSITION POSSESSING INHIBITORY ACTIVITY WITH RESPECT TO GFAT | 2004 |
|
RU2320648C2 |
SECURITY ELEMENTS AND METHOD FOR THEIR MANUFACTURE | 2014 |
|
RU2663063C2 |
CHOLESTERIC PHOTOACTIVE COMPOUND FOR GENERATING LASER EMISSION | 2006 |
|
RU2325421C1 |
CONTINUOUS METHOD FOR OBTAINING CARBONYL COMPOUNDS BY MEANS OF NITROXYL RADICAL-CONTAINING CATALYST | 2011 |
|
RU2579510C2 |
DERIVATIVES OF INDOLIN-2-SHE AS INHIBITORS OF PROTEINKINAS | 2013 |
|
RU2627706C2 |
POLYMER BOUND VAT DYES | 2012 |
|
RU2618742C2 |
3-ALKOXYCARBONYLTHIADIAZINONES, METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION | 1996 |
|
RU2162087C2 |
HEPATITIS B VIRUS (HBV) INHIBITOR | 2019 |
|
RU2726456C1 |
Authors
Dates
2018-08-21—Published
2015-03-27—Filed